Source recordFED

Eupraxia Pharmaceuticals Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2019· $924,000· BN 818717308· BC

Description

Development of a sustained-release, antibiotic drug product that is more effective than the current treatments for the prophylactic prevention of post-surgical infections will be advanced through preclinical studies towards clinical trials.

Amendment chain · 2 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $999,000 at start, $924,000 after amendment #1 (−$75,000).

$999,000$0Original · 2019-02-01 (start date) · total $999,000Amendment 1 · 2019-12-13 · total $924,000
  • #02019-02-01$999,000
  • #12019-12-13$924,000-$75,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2019-02-01(start date)$999,000—Development of a sustained-release, antibiotic drug product that is more effective than the current treatments…
#1 amendment2019-12-13$924,000−$75,000Development of a sustained-release, antibiotic drug product that is more effective than the current treatments…

Related records · 11

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 818717308)

RefDepartment · programCurrent valueFY
172-2021-2022-Q3-979716National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$700,000FY2022
172-2021-2022-Q1-970191National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Youth Employment Program$36,000FY2022
172-2020-2021-Q4-967164National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$75,868FY2021
172-2020-2021-Q3-960458National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$201,964FY2021
172-2020-2021-Q1-949460National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program$142,296FY2021
172-2018-2019-Q1-905903National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$255,400FY2019

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q4-923765 · retrieved 2026-11-16.